Related Experiment Video
Updated: May 10, 2025

08:46
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
53.1K
Advancing Potency Assay Development for Advanced Therapy Medicinal Products: A Comprehensive Approach and Regulatory
Alaa Abdellatif1, Melissa Bou Jaoudeh1, Alex Zwiers1,2
1ProductLife Group, Courbevoie, France.
Human Gene Therapy
|April 21, 2025
Summary
Developing robust potency assays for Advanced Therapy Medicinal Products (ATMPs) requires product-specific strategies. This research proposes a framework and highlights new technologies for reliable ATMP potency testing, aligning with regulatory needs.
Area of Science:
- Biotechnology and Pharmaceutical Sciences
- Regulatory Science
- Assay Development
Background:
- Advanced Therapy Medicinal Products (ATMPs) present unique potency assay development challenges due to inherent variability and complex mechanisms.
- Current assay methodologies often struggle to accommodate product-specific needs and evolving global regulatory standards.
Purpose of the Study:
- To address the critical question of how to design robust and reliable potency assays for ATMPs.
- To propose a product-specific framework for potency assay design, development, and validation.
- To identify innovative solutions and emerging technologies for ATMP potency testing.
Main Methods:
- A mixed-methods approach was employed, integrating systematic literature reviews (2018-2024), industry report analysis, and global regulatory guideline comparisons.
- Analysis of a database of potency assays for approved, rejected, and withdrawn Cellular and Gene Therapy Products (CGTs/ATMPs) to identify challenges.
- Synthesis of data to propose a product-specific framework and highlight emerging technologies.
Main Results:
- A product-specific framework for designing, developing, and validating ATMP potency assays was proposed, considering technical and regulatory constraints.
- Emerging technologies like droplet digital PCR and reporter gene assays were identified as promising for enhancing assay precision and reliability.
- The analysis highlighted the need for flexible, risk-based strategies that adapt throughout product development.
Conclusions:
- Robust potency assay development for ATMPs necessitates adaptable, product-specific, and risk-based strategies.
- Standardization, definition of acceptable variability, and correlation of in vitro data with clinical outcomes are crucial for future advancements.
- Adoption of innovative technologies can significantly improve the reliability and precision of ATMP potency testing.
Related Concept Videos
Preclinical Development: Overview
4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K
Clinical Trials: Overview
2.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.4K
Drug Discovery: Overview
7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K
Drug Administration and Therapy Phases: Overview
385
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
385
Drug Regulation
1.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K
Prodrugs
2.3K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.3K

